Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours Β· Estimated delivery Sep 24 - Sep 29
The receiver operating characteristic curve was used to define the cut-off point
Jaenne et al, 2022
Morning Administration: Take the oral BPC-157 first thing in the morning on a completely empty stomach with a glass of water
A single molecular entity simultaneously activates both the GLP-1 receptor and the amylin receptor (calcitonin receptor complex), combining two complementary satiety and metabolic pathways: GLP-1 receptor activation : Glucose-dependent insulin secretion, glucagon suppression, delayed gastric emptying, and central appetite reduction through hypothalamic signaling Amylin receptor activation : Additional satiety signaling through the area postrema, complementary gastric emptying delay, and glucagon suppression through a distinct mechanism The unimolecular design means both receptor activations occur at a fixed ratio determined by the molecular structure
B.SungM
BPC-157 also activates growth hormone receptors specifically in tendon and ligament tissue, which is why its effects on musculoskeletal injuries are more pronounced than those of many other anti-inflammatory approaches
